Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
An advisory panel to the Centers for Disease Control and Prevention has backed the rollout of boosters for the Moderna and Johnson & Johnson vaccines.
-
The Food and Drug Administration has authorized booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines. It's also allowing "mixing and matching" of vaccines as boosters.
-
An FDA advisory committee recommends people who received the Johnson & Johnson COVID-19 vaccine be given a booster shot.
-
The FDA's advisory committee met to debate the best course ahead for improving immunity against the delta variant for people who received the Johnson & Johnson vaccine.
-
The Food and Drug Administration's vaccine advisory committee met Thursday to consider whether a Moderna booster shot is safe and helpful in the country's fight against COVID-19.
-
The investment is a response to an ongoing national shortage and follows a $2 billion investment in September to supply rapid tests to community health centers, food banks and schools. -
Ivermectin is a medication that's been around for decades, and it's been a miracle drug — against parasites. But now, ivermectin is the latest drug caught up in a COVID-19 controversy.
-
Scientists are still studying whether the deworming medicine could have any effect on COVID-19. But the frenzy over the drug has far more to do with politics than science. Here's how that happened.
-
Ivermectin is used to fight worms and other parasites in animals and humans. But people are taking it to treat COVID-19, despite warnings from experts and poisonings tied to the drug.
-
The CDC says using COVID-19 vaccines in ways that have not been authorized — such as in underage children, or as a booster dose — can leave providers and individuals uncovered if problems arise.
